Loading…

Standardisation and international adoption of defined approaches for skin sensitisation

In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable fo...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in toxicology 2022-08, Vol.4, p.943152-943152
Main Authors: Casati, Silvia, Asturiol, David, Browne, Patience, Kleinstreuer, Nicole, Régimbald-Krnel, Michèle, Therriault, Pierre
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03
cites cdi_FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03
container_end_page 943152
container_issue
container_start_page 943152
container_title Frontiers in toxicology
container_volume 4
creator Casati, Silvia
Asturiol, David
Browne, Patience
Kleinstreuer, Nicole
Régimbald-Krnel, Michèle
Therriault, Pierre
description In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable for hazard identification and potency sub-categorisation. A number of defined approaches (DAs), using fixed data interpretation procedures (DIP) to integrate data from multiple non-animal information sources, were proposed and documented using a standard reporting template developed by the Organisation for Economic Co-operation and Development (OECD). Subsequent international activities focused on the extensive characterisation of three of these DAs with respect to the reference in vivo data, applicability domains, limitations, predictive performances and characterisations of the level of confidence associated with the predictions. The ultimate product of this project was an OECD Guideline that provides information equivalent to that provided by the animal studies and that can be used to satisfy countries’ regulatory data requirements for skin sensitisation. This Defined Approach Guideline was the first of its kind for the OECD, and provides an important precedent for regulatory adoption of human biology-relevant new approach methodologies with performances equivalent to, or better than, traditional animal tests. This mini review summarizes the principal features of the defined approaches described in OECD guideline 497.
doi_str_mv 10.3389/ftox.2022.943152
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_405e5bdae3ed4a38a4f1a1b537b6a45d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_405e5bdae3ed4a38a4f1a1b537b6a45d</doaj_id><sourcerecordid>2707873228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03</originalsourceid><addsrcrecordid>eNpVkUtvFDEQhC0EIlHIneMcuezi9-OChCIIkSJxCIij1WO3E4dZe7BnUfj37EuInLqrq_T1oQh5y-haCOvep6U-rTnlfO2kYIq_IOdcG7ES1NKX_-1n5LL3R0opV4xzYV6TM6Gp4MbRc_LjboESocXcYcm1DDs15LJgKwcN0wCxzgerpiFiygXjAPPcKoQH7EOqbeg_cxk6lp6XE-cNeZVg6nh5mhfk--dP366-rG6_Xt9cfbxdBSncshIqBqatDFoYTEknKzApCGMITnM9plFJzdApsCbwoGOgjIYkg2NWR6TigtwcubHCo59b3kD74ytkfzjUdu-hLTlM6CVVqMYIKDBKEBZkYsBGJcyoQaq4Y304subtuMEYsCwNpmfQ507JD_6-_vZOUu642wHenQCt_tpiX_wm94DTBAXrtntuqLFGcG53UXqMhlZ7b5j-vWHU7-v1-3r9vl5_rFf8BR0amvY</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2707873228</pqid></control><display><type>article</type><title>Standardisation and international adoption of defined approaches for skin sensitisation</title><source>PubMed Central</source><creator>Casati, Silvia ; Asturiol, David ; Browne, Patience ; Kleinstreuer, Nicole ; Régimbald-Krnel, Michèle ; Therriault, Pierre</creator><creatorcontrib>Casati, Silvia ; Asturiol, David ; Browne, Patience ; Kleinstreuer, Nicole ; Régimbald-Krnel, Michèle ; Therriault, Pierre</creatorcontrib><description>In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable for hazard identification and potency sub-categorisation. A number of defined approaches (DAs), using fixed data interpretation procedures (DIP) to integrate data from multiple non-animal information sources, were proposed and documented using a standard reporting template developed by the Organisation for Economic Co-operation and Development (OECD). Subsequent international activities focused on the extensive characterisation of three of these DAs with respect to the reference in vivo data, applicability domains, limitations, predictive performances and characterisations of the level of confidence associated with the predictions. The ultimate product of this project was an OECD Guideline that provides information equivalent to that provided by the animal studies and that can be used to satisfy countries’ regulatory data requirements for skin sensitisation. This Defined Approach Guideline was the first of its kind for the OECD, and provides an important precedent for regulatory adoption of human biology-relevant new approach methodologies with performances equivalent to, or better than, traditional animal tests. This mini review summarizes the principal features of the defined approaches described in OECD guideline 497.</description><identifier>ISSN: 2673-3080</identifier><identifier>EISSN: 2673-3080</identifier><identifier>DOI: 10.3389/ftox.2022.943152</identifier><identifier>PMID: 36032790</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>adverse outcome pathway ; defined approaches ; international harmonisation ; mechanistic relevance ; non-animal alternative methods ; Toxicology</subject><ispartof>Frontiers in toxicology, 2022-08, Vol.4, p.943152-943152</ispartof><rights>Copyright © 2022 Casati, Asturiol, Browne, Kleinstreuer, Régimbald-Krnel and Therriault. 2022 Casati, Asturiol, Browne, Kleinstreuer, Régimbald-Krnel and Therriault</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03</citedby><cites>FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402929/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402929/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27898,27899,53763,53765</link.rule.ids></links><search><creatorcontrib>Casati, Silvia</creatorcontrib><creatorcontrib>Asturiol, David</creatorcontrib><creatorcontrib>Browne, Patience</creatorcontrib><creatorcontrib>Kleinstreuer, Nicole</creatorcontrib><creatorcontrib>Régimbald-Krnel, Michèle</creatorcontrib><creatorcontrib>Therriault, Pierre</creatorcontrib><title>Standardisation and international adoption of defined approaches for skin sensitisation</title><title>Frontiers in toxicology</title><description>In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable for hazard identification and potency sub-categorisation. A number of defined approaches (DAs), using fixed data interpretation procedures (DIP) to integrate data from multiple non-animal information sources, were proposed and documented using a standard reporting template developed by the Organisation for Economic Co-operation and Development (OECD). Subsequent international activities focused on the extensive characterisation of three of these DAs with respect to the reference in vivo data, applicability domains, limitations, predictive performances and characterisations of the level of confidence associated with the predictions. The ultimate product of this project was an OECD Guideline that provides information equivalent to that provided by the animal studies and that can be used to satisfy countries’ regulatory data requirements for skin sensitisation. This Defined Approach Guideline was the first of its kind for the OECD, and provides an important precedent for regulatory adoption of human biology-relevant new approach methodologies with performances equivalent to, or better than, traditional animal tests. This mini review summarizes the principal features of the defined approaches described in OECD guideline 497.</description><subject>adverse outcome pathway</subject><subject>defined approaches</subject><subject>international harmonisation</subject><subject>mechanistic relevance</subject><subject>non-animal alternative methods</subject><subject>Toxicology</subject><issn>2673-3080</issn><issn>2673-3080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkUtvFDEQhC0EIlHIneMcuezi9-OChCIIkSJxCIij1WO3E4dZe7BnUfj37EuInLqrq_T1oQh5y-haCOvep6U-rTnlfO2kYIq_IOdcG7ES1NKX_-1n5LL3R0opV4xzYV6TM6Gp4MbRc_LjboESocXcYcm1DDs15LJgKwcN0wCxzgerpiFiygXjAPPcKoQH7EOqbeg_cxk6lp6XE-cNeZVg6nh5mhfk--dP366-rG6_Xt9cfbxdBSncshIqBqatDFoYTEknKzApCGMITnM9plFJzdApsCbwoGOgjIYkg2NWR6TigtwcubHCo59b3kD74ytkfzjUdu-hLTlM6CVVqMYIKDBKEBZkYsBGJcyoQaq4Y304subtuMEYsCwNpmfQ507JD_6-_vZOUu642wHenQCt_tpiX_wm94DTBAXrtntuqLFGcG53UXqMhlZ7b5j-vWHU7-v1-3r9vl5_rFf8BR0amvY</recordid><startdate>20220811</startdate><enddate>20220811</enddate><creator>Casati, Silvia</creator><creator>Asturiol, David</creator><creator>Browne, Patience</creator><creator>Kleinstreuer, Nicole</creator><creator>Régimbald-Krnel, Michèle</creator><creator>Therriault, Pierre</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220811</creationdate><title>Standardisation and international adoption of defined approaches for skin sensitisation</title><author>Casati, Silvia ; Asturiol, David ; Browne, Patience ; Kleinstreuer, Nicole ; Régimbald-Krnel, Michèle ; Therriault, Pierre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>adverse outcome pathway</topic><topic>defined approaches</topic><topic>international harmonisation</topic><topic>mechanistic relevance</topic><topic>non-animal alternative methods</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casati, Silvia</creatorcontrib><creatorcontrib>Asturiol, David</creatorcontrib><creatorcontrib>Browne, Patience</creatorcontrib><creatorcontrib>Kleinstreuer, Nicole</creatorcontrib><creatorcontrib>Régimbald-Krnel, Michèle</creatorcontrib><creatorcontrib>Therriault, Pierre</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casati, Silvia</au><au>Asturiol, David</au><au>Browne, Patience</au><au>Kleinstreuer, Nicole</au><au>Régimbald-Krnel, Michèle</au><au>Therriault, Pierre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Standardisation and international adoption of defined approaches for skin sensitisation</atitle><jtitle>Frontiers in toxicology</jtitle><date>2022-08-11</date><risdate>2022</risdate><volume>4</volume><spage>943152</spage><epage>943152</epage><pages>943152-943152</pages><issn>2673-3080</issn><eissn>2673-3080</eissn><abstract>In the absence of stand-alone one-to-one replacements for existing animal tests, efforts were made to integrate data from in silico , in chemico and in vitro methods to ensure sufficient mechanistic coverage of the skin sensitisation Adverse Outcome Pathway (AOP) and generate predictions suitable for hazard identification and potency sub-categorisation. A number of defined approaches (DAs), using fixed data interpretation procedures (DIP) to integrate data from multiple non-animal information sources, were proposed and documented using a standard reporting template developed by the Organisation for Economic Co-operation and Development (OECD). Subsequent international activities focused on the extensive characterisation of three of these DAs with respect to the reference in vivo data, applicability domains, limitations, predictive performances and characterisations of the level of confidence associated with the predictions. The ultimate product of this project was an OECD Guideline that provides information equivalent to that provided by the animal studies and that can be used to satisfy countries’ regulatory data requirements for skin sensitisation. This Defined Approach Guideline was the first of its kind for the OECD, and provides an important precedent for regulatory adoption of human biology-relevant new approach methodologies with performances equivalent to, or better than, traditional animal tests. This mini review summarizes the principal features of the defined approaches described in OECD guideline 497.</abstract><pub>Frontiers Media S.A</pub><pmid>36032790</pmid><doi>10.3389/ftox.2022.943152</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2673-3080
ispartof Frontiers in toxicology, 2022-08, Vol.4, p.943152-943152
issn 2673-3080
2673-3080
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_405e5bdae3ed4a38a4f1a1b537b6a45d
source PubMed Central
subjects adverse outcome pathway
defined approaches
international harmonisation
mechanistic relevance
non-animal alternative methods
Toxicology
title Standardisation and international adoption of defined approaches for skin sensitisation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-05T19%3A11%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Standardisation%20and%20international%20adoption%20of%20defined%20approaches%20for%20skin%20sensitisation&rft.jtitle=Frontiers%20in%20toxicology&rft.au=Casati,%20Silvia&rft.date=2022-08-11&rft.volume=4&rft.spage=943152&rft.epage=943152&rft.pages=943152-943152&rft.issn=2673-3080&rft.eissn=2673-3080&rft_id=info:doi/10.3389/ftox.2022.943152&rft_dat=%3Cproquest_doaj_%3E2707873228%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-35dc1684c637eff6f83ef5acbcc9626bfb5461e95a87c2c6dc010cf4c9186de03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2707873228&rft_id=info:pmid/36032790&rfr_iscdi=true